14 SEPTEMBER NEW ZEALAND GAZETTE

United Kingdom) Act 1982 or any enactment which replaces, amends, supplants or consolidates that Act; or

(10) Is a child (who is not otherwise eligible) under the age of 16 years who is lawfully in New Zealand and is for the time being in the care and control of:

(a) his or her guardian, and his or her guardian meets any of the eligibility criteria specified in clauses 5 (1), (2) or (3); or

(b) a person who is in the process of legally adopting that child and that person meets any of the eligibility criteria specified in clauses 5 (1), (2), or (3); or

(11) Is an individual receiving compulsory services under the Tuberculosis Act 1948, the Health Act 1956, the Alcoholism and Drug Addiction Act 1966, the Mental Health (Compulsory Assessment and Treatment) Act 1992 or any regulations made under such legislation, in respect only of services under those enactments, provided that any such individual may be considered for eligibility for those services only in terms of this clause 5 (12); or

(12) Is a prison inmate, including an individual on remand in prison custody, in respect only of services not available through the prison health services, provided that any such individual may be considered for eligibility for those services only in terms of this clause 12; or

(13) Is an individual who:

(a) in respect of eligibility for public health acute services required by that person for a personal injury for which that person has cover and entitlement to treatment under the AI Act, is seeking services covered by a funding agreement; or

(b) in respect of eligibility for disability support services, requires those services for a personal injury for which the person has cover and entitlement under the AI Act, but has been disentitled to any of those services under any of sections 117-123 of the AI Act;

(c) Has cover and entitlement under the AI Act, and seeks primary-referred pharmaceutical and laboratory services.

Notwithstanding this clause 5 (13), a person who has cover and statutory entitlement in respect of a personal injury under the AI Act is not eligible for publicly funded services in relation to that injury except as provided in this clause 5 (13), and may not demonstrate eligibility for services in respect of that injury under clause 5 (1)-(12) of this Direction.

6. General—(1) Eligibility according to the eligibility criteria is to be assessed at the time the service is sought.

(2) A person may, unless otherwise stated, be eligible under 1 or more of the eligibility criteria.

(3) No payment shall be made by the HFA in respect of the receipt of a service by an eligible person who was not within New Zealand at the time of that receipt, unless such payment is authorised in a funding agreement.

Dated at Wellington this 27th day of July 2000.

ANNETTE KING, Minister of Health.

1 “Entitlement” in clause 5 (13)(a) means a person who has statutory entitlements in terms of Part I of Schedule 1 to the AI Act.

2 “Entitlement” in clause 5 (13)(b) means a person who has statutory entitlement to disability support services in terms of Schedule 1 to the AI Act.

3 The services covered by subclause 5 (13)(c) are outlined in the 2000/2001 Crown-ACC funding agreement for primary-referred pharmaceutical and laboratory services between ACC and the Minister of Health.

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Intron A Redipen
Active Ingredient(s): Interferon alfa-2b 15MIU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Schering-Plough Pty Limited
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Product: Intron A Redipen
Active Ingredient(s): Interferon alfa-2b 25MIU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Schering-Plough Pty Limited
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Product: Intron A Redipen
Active Ingredient(s): Interferon alfa-2b 50MIU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Schering-Plough Pty Limited
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Product: Intron-A
Active Ingredient(s): Interferon alfa-2b 10MIU
Dosage Form: Powder for injection
New Zealand Sponsor: Schering-Plough Pty Limited
Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland